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Background: Young, healthy children shedding cytomegalovirus (CMV) in urine and saliva appear to be the leading
source of CMV in primary infection of pregnant women.
Findings: We screened 48 children 6 months – 5 years old for CMV IgG and measured levels of CMV IgG, IgM and IgG
avidity antibodies, frequency of CMV shedding, and viral loads in blood, urine, and saliva. Thirteen of the 48 children
(27%) were CMV IgG positive, among whom 3 were also CMV IgM positive with evidence of recent primary infection.
Nine of the 13 seropositive children (69%) were shedding 102-105 copies/ml of CMV DNA in one or more bodily fluid.
Among seropositive children, low IgG antibody titer (1:20–1:80) was associated with the absence of shedding
(p = 0.014), and enrollment in daycare was associated with the presence of CMV shedding (p = 0.037).
Conclusions: CMV antibody profiles correlated with CMV shedding. The presence of CMV IgM more often represents
primary infection in children than in adults. Correlating antibodies with primary infection and viral shedding in healthy
children adds to the understanding of CMV infection in children that can inform the prevention of CMV transmission
to pregnant women.
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Infection with human cytomegalovirus (CMV) is typically
harmless for children and adults but can have serious con-
sequences for immunocompromised persons and develop-
ing fetuses. In the United States, 0.5 - 1% (20,000 - 40,000)
of infants are born with congenital CMV infection each
year and approximately 20% of them (4,000 - 8,000) de-
velop permanent disabilities such as hearing loss, visual
impairment, and mental retardation [1,2]. CMV infection
occurs through close interpersonal contact with infected
bodily fluids and usually confers no symptoms. Young
children who become infected often shed CMV in urine
and saliva for a year or more and are thought to be the
leading source of CMV for primary infection in women of
reproductive age [3-7]. Several studies have shown shed-
ding of CMV virus in young children mainly by perform-
ing viral culture on urine or saliva [7-9]. However most
studies tested a single specimen type and very few studies* Correspondence: sgd5@cdc.gov
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unless otherwise stated.measured virus in blood or included serology to identify
the proportion of children with CMV infection that were
shedding.
The main objective of this study was to examine CMV
antibody profiles in young children as they relate to
virus levels across urine, saliva, and blood. This report
provides new information on the frequency of shedding
among CMV seropositive children, including identifica-
tion of primary infection, and compares CMV viral loads
across fluids collected at the same time. Knowledge of
associations between immune-response parameters and
CMV shedding and viral loads in bodily fluids may en-
hance understanding of natural CMV infection in tod-
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children between the ages of 6 and 60 months who were
having blood drawn for other purposes at four Emory
University outpatient pediatric clinics. The enrollment
questionnaire collected information on age, sex, attend-
ance in daycare (institutional or home-based), race/eth-
nicity, and type of health insurance as a marker for
socioeconomic status (SES). We did not have informa-
tion on the timing of CMV infection for any children
since CMV is typically an asymptomatic infection. We
did not have information on whether any of the 13 sero-
positive children may have been born with CMV, but
this would have low probability since the congenital
CMV infection rate is approximately 0.65% (1 per 154
infants) [2].
There was a one-time collection of 3 bodily fluids:
whole blood, urine, and saliva. Whole blood was col-
lected through venipuncture into EDTA Vacuatiners
(Becton-Dickinson, New Jersey, USA) with a portion
processed for antibody testing. CMV IgG and IgM status
were determined by VIDAS. End-point titer was per-
formed by immunofluorescense assay (IFA) (MBL-Bion,
Des Plaines, IL) because the IFA requires far less speci-
men volume than the VIDAS. IgG avidity was measured
with 3 tests (Euroimmun, Vidia, and VIDAS) because of
reports of low concordance among commercial CMV
avidity tests [10]. Interpretation of the Euroimmun and
Vidia tests followed manufacturer’s instructions. Inter-
pretation of the VIDAS was adjusted to provide im-
proved sensitivity [11-13]. Final avidity determination
was based on agreement of two or more tests results.
Saliva was collected with the Oracol foam swab (Malvern












H1 Black Low 1:20 13
H2 Black Low 1:20 7
H3 Black Med/High 1:20 11
H4 White-NH Med/High 1:1280 154
H5 White-His Low 1:40 12
D1 White-His Low 1:320 91
D2 Black Low 1:320 64
D3 White-NH Med/High 1:320 74
D4 White-NH Low 1:160 48
D5 Black Low 1:160 60
D6 Black Med/High 1:1280 110
D7 Black Med/High 1:320 41
D8 White-His Low 1:80 37
*NH = non-Hispanic; His = Hispanic. **Cutoff values for Euroimmun CMV avidity teswas collected by having children urinate into a specimen
cup with their mothers helping as needed. Total DNA was
extracted from whole blood, urine, and saliva using the
MagNAPure with DNA extraction kits (Roche Diagnostics)
followed by Taqman-based PCR [14,15]. Viral copy num-
bers were normalized to the input volume for each speci-
men so that viral loads were comparable across the 3
bodily fluids. Statistical significance for various associa-
tions was calculated using Fisher’s exact test (two-tailed,
95% confidence interval). Differences in CMV viral load
by specimen type were compared using a two-sided t-test
with unequal variances.
Results
Total enrollment was 48 children; 54% were male and
46% were female; 18% were 6–11 months old, 74% were
1–2 years old, and 8% were 3–4 years old. Blood was
collected from all 48 enrolled children, saliva was col-
lected from 46/48 (96%) children, and urine was col-
lected from only 26/48 (54%) children because many of
them were unable to produce urine during the 30 minute
clinic visit. VIDAS determinations for IgG and IgM were
the same as those by IFA. CMV IgG was detected in 13/
48 (27%) of the children (Table 1) all of whom were over
12 months old, eliminating the possible interference of
maternal antibody. Their racial/ethnic makeup and SES
are shown on Table 1. Three of the IgG-positive children
were CMV IgM-positive. Among IgM positive sera, two
were low IgG avidity and one was low-intermediate IgG
avidity (Table 1), indicating that all three represented
primary infection. Two out of 3 IgM-positive sera had
virus in bodily fluids that might suggest a correlation be-













- 48.32 Interm - -
- 61.89 High - -
- 65.36 High 718 133
- 79.00 High 994 84
- 78.72 High - -
1:160 25.92 Low 7,212 550
- 63.69 High 3,130 287
- 72.87 High 92,056 -
- 73.82 High 24,722 207
- 76.77 High 17,181 -
1:20 35.21 Low - 92
- 72.33 High 244 -
1:20 42.24 Interm - -
t: <40 = low avidity, 40–60 = intermediate avidity, >60 = high avidity.
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complete agreement for 10/13 sera and had imperfect
agreement for the following 3 borderline sera: H1 had
two intermediate values and one high value; D6 had two
low values and one intermediate value; D8 had two
intermediate values and one low value. Results of the
Euroimmun test were in the majority result for all sera
and are shown in Table 1. Ten of the 13 antibody-
positive children (69%) had CMV DNA in one or more
bodily fluid. Shedding in urine is not shown on Table 1
because of the low number of specimens collected. The
prevalence of CMV DNA was 62% (8/13) for saliva and
46% (6/13) for blood (Table 1). Geometric mean viral
loads were 3727 copies/ml for urine, 4449 copies/ml for
saliva, and 172 copies/ml for blood. The difference in
mean viral loads was statistically significant for saliva
and blood (p = 0.01). There were too few urine samples
to include them in analysis. The 3 positive urine samples
had the following viral loads: (Table 1 child numbers)
D4: 27,756 copies/ml, D6: 667 copies/ml, and D7: 2,798
copies/ml. None of the 35 CMV IgG-negative children
had CMV DNA in any bodily fluid. Enrollment in day-
care showed a significant association with CMV viral
shedding (p = 0.037). Low IgG antibody titer, defined as
endpoint titer 1:20–1:80 (range 1:20 – 1:1280), was asso-
ciated with the absence of shedding (p = 0.014). Age,
race/ethnicity, and socioeconomic status showed no as-
sociation with CMV antibody positivity or shedding;
however, the small sample size had limited ability to
show associations.
Discussion
The main objective of this study was to measure CMV
viral loads in urine, saliva, and blood compared to anti-
body profiles to identify possible correlates between ser-
ology and shedding. Many studies have reported CMV
shedding in urine and saliva of young children. The
unique aspect of our study was the inclusion of CMV
serology. We observed a strong correlation between
CMV shedding (the presence of CMV DNA in any bod-
ily fluid) and enrollment in daycare previously reported
that indicates that spread of CMV occurs in daycare
centers [16,17]. New and suggestive findings include: (1)
A significant correlation between low IgG titers and the
absence of CMV shedding; (2) High association between
IgM-positive status and recent primary infection, in con-
trast to CMV IgM in adults for which less than 20% is
estimated to represent recent primary infection [11,18].
(3) Prolonged CMV viremia; among nine children with
evidence of infection more than 4 months prior, four
(44%) were still viremic. This is consistent with long pe-
riods of CMV shedding in children and contrasts with
adults who show much shorter periods of CMV viremia
following primary infection [19].Our study had the main limitation of small numbers
due to lower enrollment than expected and can only
provide a basis for future studies. One potential study
could establish whether CMV IgM reactivity in young
children usually indicates primary CMV infection. This
would be expected since younger people experience
more primary than non-primary infection, and is sup-
ported by a US population based study showing that the
presence of CMV IgM in adolescents is far more associ-
ated with low IgG avidity than CMV IgM in adults [11].
Among the 13 seropositive children, 9 (69%) had CMV
in urine, saliva, or blood. This is likely an underestimate
for CMV shedding for two reasons, because we tested a
single time point for a virus that can shed intermittently
[7], and because urine is a common vehicle for CMV
shedding [7] and was not available for half the children.
Larger studies may also explore possible correlations be-
tween CMV antibody titer and CMV shedding.
Conclusions
Our study found that 9 of 13 CMV seropositive children
(69%) were shedding virus in one or more bodily fluid.
Extended periods of CMV shedding in young children
have been reported [7] and are in contrast to shorter
duration of CMV shedding in adults [20] which may ex-
plain the major role of young children in CMV transmis-
sion. Few studies on CMV in children have included
serology and our study suggests serology may provide
useful information beyond infection status regarding the
timing of infection and shedding correlates: CMV IgM
was more associated with primary infection compared to
adults, and children with low IgG titers were less likely
to be IgM-positive or to be shedding, possibly reflecting
more elapsed time since primary infection. Noninvasive
determination CMV serostatus of young children, for ex-
ample from a finger prick, may contribute useful infor-
mation to infection prevention measures. Larger studies
would be necessary to verify relationships between ser-
ology and viral shedding suggested by the present study
that may aid the understanding and prevention of CMV
transmission to pregnant women.
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